Jaimie Ann Clodfelter, DO Physical Medicine & Rehabilitation - Pain Medicine Medicare: Medicare Enrolled Practice Location: 3911 Avenue B, Suite 2300, Scottsbluff, NE 69361 Phone: 308-630-2992 Fax: 308-630-2995 |
Leslie Susan Cavazos, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3911 Avenue B Ste 2300, Scottsbluff, NE 69361 Phone: 308-630-1055 Fax: 308-630-2060 |
Dr. Masumi K. Wilroy, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3911 Avenue B, Suite 2300, Scottsbluff, NE 69361 Phone: 308-630-1055 |
Dr. Richard 'gregg' Wilroy Jr., D.O. Physical Medicine & Rehabilitation - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 3911 Avenue B, Suite 2300, Scottsbluff, NE 69361 Phone: 308-630-2992 |
Scott Ryne Asher, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 4021 Avenue B, Scottsbluff, NE 69361 Phone: 308-635-3711 |
News Archive
Hands pressed to the hips or perhaps leaning back with arms crossed behind the head are typical poses of power. Referred to power poses or high status gestures in technical jargon, they are assumed to stimulate both psychological and physiological processes.
Today's headlines include a report that congressional conservatives are fighting amongst themselves over health law strategies.
A new CRISPR/Cas9 technology developed by scientists at the University of Massachusetts Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
Peplin, Inc. today announced that it has completed its merger with LEO Pharma A/S (LEO) after obtaining the approval of the majority of Peplin stockholders. The deal was originally announced on 3 September, 2009 when LEO, a privately-held, leading global pharmaceutical company within Dermatology and Critical Care, agreed to acquire all outstanding securities of Peplin for approximately US$287.5 million in cash. The merger consideration will be distributed to holders of common stock and CDIs promptly.
A new survey, Asthma Insight and Management in Europe and Canada (EUCAN AIM), reveals that a majority of Canadians with asthma considered their disease "well controlled" at the time of the survey. However, in the year prior to the survey, more than half (52 per cent) required acute treatment for asthma, including seeing a doctor for worsening symptoms (45 per cent), unscheduled emergency room visits (28 per cent), and being hospitalized overnight (five per cent).
› Verified 7 days ago